|
1
|
Rizvi S, Khan SA, Hallemeier CL, Kelley RK
and Gores GJ: Cholangiocarcinoma-evolving concepts and therapeutic
strategies. Nat Rev Clin Oncol. 15:95–111. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song Y, Cai M, Li Y and Liu S: The focus
clinical research in intrahepatic cholangiocarcinoma. Eur J Med
Res. 27:1162022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Banales JM, Marin JJG, Lamarca A,
Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen
JB, Braconi C, et al: Cholangiocarcinoma 2020: The next horizon in
mechanisms and management. Nat Rev Gastroenterol Hepatol.
17:557–588. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Everhart JE and Ruhl CE: Burden of
digestive diseases in the United States part III: Liver, biliary
tract, and pancreas. Gastroenterology. 136:1134–1144. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khan SA, Davidson BR, Goldin RD, Heaton N,
Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD,
Thillainayagam AV, et al: Guidelines for the diagnosis and
treatment of cholangiocarcinoma: An update. Gut. 61:1657–1669.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Song Y and Liu S: The new insight of
treatment in Cholangiocarcinoma. J Cancer. 13:450–464. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valero V III, Cosgrove D, Herman JM and
Pawlik TM: Management of perihilar cholangiocarcinoma in the era of
multimodal therapy. Expert Rev Gastroenterol Hepatol. 6:481–495.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Glazer ES, Liu P, Abdalla EK, Vauthey JN
and Curley SA: Neither neoadjuvant nor adjuvant therapy increases
survival after biliary tract cancer resection with wide negative
margins. J Gastrointest Surg. 16:1666–16671. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Valle J, Wasan H, Palmer DH, Cunningham D,
Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira
SP, et al: Cisplatin plus gemcitabine versus gemcitabine for
biliary tract cancer. N Engl J Med. 362:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dolmans DE, Fukumura D and Jain RK:
Photodynamic therapy for cancer. Nat Rev Cancer. 3:380–387. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McCaughan JS Jr, Mertens BF, Cho C,
Barabash RD and Payton HW: Photodynamic therapy to treat tumors of
the extrahepatic biliary ducts. A case report. Arch Surg.
126:111–113. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rerknimitr R, Angsuwatcharakon P,
Ratanachu-ek T, Khor CJ, Ponnudurai R, Moon JH, Seo DW,
Pantongrag-Brown L, Sangchan A, Pisespongsa P, et al: Asia-Pacific
consensus recommendations for endoscopic and interventional
management of hilar cholangiocarcinoma. J Gastroenterol Hepatol.
28:593–607. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agostinis P, Berg K, Cengel KA, Foster TH,
Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel
D, et al: Photodynamic therapy of cancer: An update. CA Cancer J
Clin. 61:250–281. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baptista MS, Cadet J, Di Mascio P, Ghogare
AA, Greer A, Hamblin MR, Lorente C, Nunez SC, Ribeiro MS, Thomas
AH, et al: Type I and type II guidelines and mechanistic pathways.
Photochem Photobiol. 93:912–919. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Castano AP, Mroz P and Hamblin MR:
Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer.
6:535–545. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen B, Roskams T and de Witte PA:
Antivascular tumor eradication by hypericin-mediated photodynamic
therapy. Photochem Photobiol. 76:509–513. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maharjan PS and Bhattarai HK: Singlet
oxygen, photodynamic therapy, and mechanisms of cancer cell death.
J Oncol. 2022:72114852022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brown SB, Brown EA and Walker I: The
present and future role of photodynamic therapy in cancer
treatment. Lancet Oncol. 5:497–508. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yanovsky RL, Bartenstein DW, Rogers GS,
Isakoff SJ and Chen ST: Photodynamic therapy for solid tumors: A
review of the literature. Photodermatol Photoimmunol Photomed.
35:295–303. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lucky SS, Soo KC and Zhang Y:
Nanoparticles in photodynamic therapy. Chem Rev. 115:1990–2042.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fan W, Huang and Chen X: Overcoming the
Achilles' heel of photodynamic therapy. Chem Soc Rev. 45:6488–6519.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu F, Xu S and Liu B: Photosensitizers
with aggregation-induced emission: Materials and biomedical
applications. Adv Mater. 30:e18013502018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mroz P, Yaroslavsky A, Kharkwal GB and
Hamblin MR: Cell death pathways in photodynamic therapy of cancer.
Cancers (Basel). 3:2516–2539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Jiang C, Longo JP, Azevedo RB,
Zhang H and Muehlmann LA: An updated overview on the development of
new photosensitizers for anticancer photodynamic therapy. Acta
Pharm Sin B. 8:137–146. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kniebuhler G, Pongratz T, Betz CS, Göke B,
Sroka R, Stepp H and Schirra J: Photodynamic therapy for
cholangiocarcinoma using low dose mTHPC (Foscan(®)).
Photodiagnosis Photodyn Ther. 10:220–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wagner A, Denzer UW, Neureiter D,
Kiesslich T, Puespoeck A, Rauws EA, Emmanuel K, Degenhardt N, Frick
U, Beuers U, et al: Temoporfin improves efficacy of photodynamic
therapy in advanced biliary tract carcinoma: A multicenter
prospective phase II study. Hepatology. 62:1456–1465. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mattioli EJ, Ulfo L, Marconi A, Pellicioni
V, Costantini PE, Marforio TD, Di Giosia M, Danielli A, Fimognari
C, Turrini E and Calvaresi M: Carrying temoporfin with human serum
albumin: A new perspective for photodynamic application in head and
neck cancer. Biomolecules. 13:682022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen K, Yin B, Luo Q, Liu Y, Wang Y, Liao
Y, Li Y, Chen X, Sun B, Zhou N, et al: Endoscopically guided
interventional photodynamic therapy for orthotopic pancreatic
ductal adenocarcinoma based on NIR-II fluorescent nanoparticles.
Theranostics. 13:4469–4481. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stein NC, Mulac D, Fabian J, Herrmann FC
and Langer K: Nanoparticle albumin-bound mTHPC for photodynamic
therapy: Preparation and comprehensive characterization of a
promising drug delivery system. Int J Pharm. 582:1193472020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Grunebaum J, Söbbing J, Mulac D and Langer
K: Nanoparticulate carriers for photodynamic therapy of
cholangiocarcinoma: In vitro comparison of various polymer-based
nanoparticles. Int J Pharm. 496:942–952. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kurokawa H, Ito H and Matsui H:
Porphylipoprotein accumulation and porphylipoprotein photodynamic
therapy effects involving cancer cell-specific cytotoxicity. Int J
Mol Sci. 22:73062021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dias LM, de Keijzer MJ, Ernst D, Sharifi
F, de Klerk DJ, Kleijn TG, Desclos E, Kochan JA, de Haan LR,
Franchi LP, et al: Metallated phthalocyanines and their hydrophilic
derivatives for multi-targeted oncological photodynamic therapy. J
Photochem Photobiol B. 234:1125002022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zheng B, Zhong D, Xi T, Zhou J, Li W, Ilya
A, Lu Y, Zhou M and Deng R: Near-infrared photosensitization via
direct triplet energy transfer from lanthanide nanoparticles. Chem.
7:1615–1625. 2021. View Article : Google Scholar
|
|
34
|
Lu K, He C and Lin W: Nanoscale
metal-organic framework for highly effective photodynamic therapy
of resistant head and neck cancer. J Am Chem Soc. 136:16712–1675.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Alves SR, Calori IR and Tedesco AC:
Photosensitizer-based metal-organic frameworks for highly effective
photodynamic therapy. Mater Sci Eng C Mater Biol Appl.
131:1125142021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Oleinick NL and Evans HH: The photobiology
of photodynamic therapy: Cellular targets and mechanisms. Radiat
Res. 150 (5 Suppl):S146–S156. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Agarwal ML, Clay ME, Harvey EJ, Evans HH,
Antunez AR and Oleinick NL: Photodynamic therapy induces rapid cell
death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res.
51:5993–5996. 1991.PubMed/NCBI
|
|
38
|
He JL, Guo MT, Tang L, Li B, Ma T and Cao
Z: Multifunctional DNA nanosphere platform for real-time monitoring
and fluorescence imaging-guided photodynamic therapy. Sensors and
Actuators B: Chemical. 399:1347192024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Buytaert E, Dewaele M and Agostinis P:
Molecular effectors of multiple cell death pathways initiated by
photodynamic therapy. Biochim Biophys Acta. 1776:86–107.
2007.PubMed/NCBI
|
|
40
|
Ortel B, Shea CR and Calzavara-Pinton P:
Molecular mechanisms of photodynamic therapy. Front Biosci
(Landmark Ed). 14:4157–4172. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
He C, Xia J, Gao Y, Chen Z and Wan X:
Chlorin A-mediated photodynamic therapy induced apoptosis in human
cholangiocarcinoma cells via impaired autophagy flux. Am J Transl
Res. 12:5080–5094. 2020.PubMed/NCBI
|
|
42
|
Casini A, Leone S, Vaccaro R, Vivacqua G,
Ceci L, Pannarale L, Franchitto A, Onori P, Gaudio E and Mancinelli
R: The emerging role of ferroptosis in liver cancers. Life (Basel).
12:21282022.PubMed/NCBI
|
|
43
|
Zhang ZJ, Huang YP, Li XX, Liu ZT, Liu K,
Deng XF, Xiong L, Zou H and Wen Y: A novel ferroptosis-related
4-gene prognostic signature for cholangiocarcinoma and photodynamic
therapy. Front Oncol. 11:7474452021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Preise D, Scherz A and Salomon Y:
Antitumor immunity promoted by vascular occluding therapy: Lessons
from vascular-targeted photodynamic therapy (VTP). Photochem
Photobiol Sci. 10:681–688. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen B, Crane C, He C, Gondek D, Agharkar
P, Savellano MD, Hoopes PJ and Pogue BW: Disparity between prostate
tumor interior versus peripheral vasculature in response to
verteporfin-mediated vascular-targeting therapy. Int J Cancer.
123:695–701. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu Y, Deng F, Zheng R, Chen X, Zhao L, Yu
B, Chen A, Jiang X, Cheng H and Li S: Self-delivery nanomedicine
for vascular disruption-supplemented chemo-photodynamic tumor
therapy. J Colloid Interface Sci. 612:562–571. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhou J, Wang G, Chen Y, Wang H, Hua Y and
Cai Z: Immunogenic cell death in cancer therapy: Present and
emerging inducers. J Cell Mol Med. 23:4854–4865. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Correia JH, Rodrigues JA, Pimenta S, Dong
T and Yang Z: Photodynamic therapy review: Principles,
photosensitizers, applications, and future directions.
Pharmaceutics. 13:13322021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li W, Yang J, Luo L, Jiang M, Qin B, Yin
H, Zhu C, Yuan X, Zhang J, Luo Z, et al: Targeting photodynamic and
photothermal therapy to the endoplasmic reticulum enhances
immunogenic cancer cell death. Nat Commun. 10:33492019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liao S, Wang Y, Li Z, Zhang Y, Yin X, Huan
S, Zhang XB, Liu S and Song G: A novel afterglow nanoreporter for
monitoring cancer therapy. Theranostics. 12:6883–6897. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ji B, Wei M and Yang B: Recent advances in
nanomedicines for photodynamic therapy (PDT)-driven cancer
immunotherapy. Theranostics. 12:434–458. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mansour JC, Aloia TA, Crane CH, Heimbach
JK, Nagino M and Vauthey JN: Hilar cholangiocarcinoma: Expert
consensus statement. HPB (Oxford). 17:691–699. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Witzigmann H, Berr F, Ringel U, Caca K,
Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J,
Hauss J and Wiedmann M: Surgical and palliative management and
outcome in 184 patients with hilar cholangiocarcinoma: Palliative
photodynamic therapy plus stenting is comparable to r1/r2
resection. Ann Surg. 244:230–239. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zoepf T, Jakobs R, Arnold JC, Apel D and
Riemann JF: Palliation of nonresectable bile duct cancer: Improved
survival after photodynamic therapy. Am J Gastroenterol.
100:2426–2430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen P, Yang T, Shi P, Shen J, Feng Q and
Su J: Benefits and safety of photodynamic therapy in patients with
hilar cholangiocarcinoma: A meta-analysis. Photodiagnosis Photodyn
Ther. 37:1027122022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhou J, Xiong L, Liu W, Liu C, He C, Zou
H, Wen Y and Lin L: SpyGlass-guided photodynamic therapy for
unresectable cholangiocarcinoma: A case report and review of the
literature. Front Oncol. 12:8907352022. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lee TY, Cheon YK and Shim CS: Photodynamic
therapy in patients with advanced hilar cholangiocarcinoma:
Percutaneous cholangioscopic versus peroral transpapillary
approach. Photomed Laser Surg. 34:150–156. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Mukai T, Yasuda I, Nakashima M, Doi S,
Iwashita T, Iwata K, Kato T, Tomita E and Moriwaki H: Metallic
stents are more efficacious than plastic stents in unresectable
malignant hilar biliary strictures: A randomized controlled trial.
J Hepatobiliary Pancreat Sci. 20:214–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lee TY, Cheon YK, Shim CS and Cho YD:
Photodynamic therapy prolongs metal stent patency in patients with
unresectable hilar cholangiocarcinoma. World J Gastroenterol.
18:5589–5594. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Bae BC, Yang SG, Jeong S, Lee DH, Na K,
Kim JM, Costamagna G, Kozarek RA, Isayama H, Deviere J, et al:
Polymeric photosensitizer-embedded self-expanding metal stent for
repeatable endoscopic photodynamic therapy of cholangiocarcinoma.
Biomaterials. 35:8487–8495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liang PC, Huang KW, Tung CC, Chang MC,
Chang FY, Wong JM and Chang YT: A novel photodynamic therapy-based
drug delivery system layered on a stent for treating
cholangiocarcinoma. Biomed Microdevices. 20:32017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Luvira V, Satitkarnmanee E, Pugkhem A,
Kietpeerakool C, Lumbiganon P and Pattanittum P: Postoperative
adjuvant chemotherapy for resectable cholangiocarcinoma. Cochrane
Database Syst Rev. 9:CD0128142021.PubMed/NCBI
|
|
63
|
Shroff RT, Kennedy EB, Bachini M,
Bekaii-Saab T, Crane C, Edeline J, El-Khoueiry A, Feng M, Katz MHG,
Primrose J, et al: Adjuvant therapy for resected biliary tract
cancer: ASCO clinical practice guideline. J Clin Oncol.
37:1015–1027. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Nanashima A, Yamaguchi H, Shibasaki S, Ide
N, Sawai T, Tsuji T, Hidaka S, Sumida Y, Nakagoe T and Nagayasu T:
Adjuvant photodynamic therapy for bile duct carcinoma after
surgery: A preliminary study. J Gastroenterol. 39:1095–1101. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Chen Z, Jiang X, Xue P, Chen S, Li S, Li
Z, Pan W and Zhang D: Long-term efficacy of percutaneous
transhepatic cholangioscopy-guided photodynamic therapy for
postoperative recurrent extrahepatic cholangiocarcinoma.
Photodiagnosis Photodyn Ther. 40:1031222022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wiedmann M, Caca K, Berr F, Schiefke I,
Tannapfel A, Wittekind C, Mössner J, Hauss J and Witzigmann H:
Neoadjuvant photodynamic therapy as a new approach to treating
hilar cholangiocarcinoma: A phase II pilot study. Cancer.
97:2783–2790. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wagner A, Wiedmann M, Tannapfel A, Mayr C,
Kiesslich T, Wolkersdörfer GW, Berr F, Hauss J and Witzigmann H:
Neoadjuvant down-sizing of hilar cholangiocarcinoma with
photodynamic therapy-long-term outcome of a phase II pilot study.
Int J Mol Sci. 16:26619–2628. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Cosgrove ND, Al-Osaimi AM, Sanoff HK,
Morris MM, Read PW, Cox DG, Mann JA, Argo CK, Berg CL, Pelletier
SJ, et al: Photodynamic therapy provides local control of
cholangiocarcinoma in patients awaiting liver transplantation. Am J
Transplant. 14:466–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kiesslich T, Wolkersdörfer G, Neureiter D,
Salmhofer H and Berr F: Photodynamic therapy for non-resectable
perihilar cholangiocarcinoma. Photochem Photobiol Sci. 8:23–30.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Fayter D, Corbett M, Heirs M, Fox D and
Eastwood A: A systematic review of photodynamic therapy in the
treatment of pre-cancerous skin conditions, Barrett's oesophagus
and cancers of the biliary tract, brain, head and neck, lung,
oesophagus and skin. Health Technol Assess. 14:1–288. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Bartusik-Aebisher D, Osuchowski M,
Adamczyk M, Stopa J, Cieślar G, Kawczyk-Krupka A and Aebisher D:
Advancements in photodynamic therapy of esophageal cancer. Front
Oncol. 12:10245762022. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Wu H, Minamide T and Yano T: Role of
photodynamic therapy in the treatment of esophageal cancer. Dig
Endosc. 31:508–516. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zaar O, Fougelberg J, Hermansson A,
Gillstedt M, Wennberg-Larkö AM and Paoli J: Effectiveness of
photodynamic therapy in Bowen's disease: A retrospective
observational study in 423 lesions. J Eur Acad Dermatol Venereol.
31:1289–1294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Konopka K and Goslinski T: Photodynamic
therapy in dentistry. J Dent Res. 86:694–707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Hopper C: Photodynamic therapy: A clinical
reality in the treatment of cancer. Lancet Oncol. 1:212–219. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Eckel F and Schmid RM: Chemotherapy in
advanced biliary tract carcinoma: A pooled analysis of clinical
trials. Br J Cancer. 96:896–902. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Okusaka T, Nakachi K, Fukutomi A, Mizuno
N, Ohkawa S, Funakoshi A, Nagino M, Kondo S, Nagaoka S, Funai J, et
al: Gemcitabine alone or in combination with cisplatin in patients
with biliary tract cancer: A comparative multicentre study in
Japan. Br J Cancer. 103:469–474. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yang Y, Li J, Yao L and Wu L: Effect of
photodynamic therapy on gemcitabine-resistant cholangiocarcinoma in
vitro and in vivo Through KLF10 and EGFR. Front Cell Dev Biol.
9:7107212021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Gonzalez-Carmona MA, Bolch M, Jansen C,
Vogt A, Sampels M, Mohr RU, van Beekum K, Mahn R, Praktiknjo M,
Nattermann J, et al: Combined photodynamic therapy with systemic
chemotherapy for unresectable cholangiocarcinoma. Aliment Pharmacol
Ther. 49:437–447. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Park DH, Lee SS, Park SE, Lee JL, Choi JH,
Choi HJ, Jang JW, Kim HJ, Eum JB, Seo DW, et al: Randomised phase
II trial of photodynamic therapy plus oral fluoropyrimidine, S-1,
versus photodynamic therapy alone for unresectable hilar
cholangiocarcinoma. Eur J Cancer. 50:1259–1268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yu Y, Wang N, Wang Y, Shi Q, Yu R, Gu B,
Maswikiti EP and Chen H: Photodynamic therapy combined with
systemic chemotherapy for unresectable extrahepatic
cholangiocarcinoma: A systematic review and meta-analysis.
Photodiagnosis Photodyn Ther. 41:1033182023. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Hong MJ, Cheon YK, Lee EJ, Lee TY and Shim
CS: Long-term outcome of photodynamic therapy with systemic
chemotherapy compared to photodynamic therapy alone in patients
with advanced hilar cholangiocarcinoma. Gut Liver. 8:318–323. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Liu Y, Long K, Kang W, Wang T and Wang W:
Optochemical control of immune checkpoint blockade via
light-triggered PD-L1 Dimerization. Advance NanoBioMed Research.
2:2200017. 2022.
|
|
84
|
Bao R, Wang Y, Lai J, Zhu H, Zhao Y, Li S,
Li N, Huang J, Yang Z, Wang F and Liu Z: Enhancing anti-PD-1/PD-L1
immune checkpoint inhibitory cancer therapy by CD276-targeted
photodynamic ablation of tumor cells and tumor vascu lature. Mol
Pharm. 16:339–348. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Brackett CM and Gollnick SO: Photodynamic
therapy enhancement of anti-tumor immunity. Photochem Photobiol
Sci. 10:649–652. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Gu X, Wu B, Feng G, Chen Z, Re F, Che X,
Hong W and Li W: PD-L1 blockade peptide-modified polymeric
nanoparticles for oxygen-independent-based hypoxic tumor
photo/thermodynamic immunotherapy. Mol Pharm. 20:4007–4020. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Bown SG, Rogowska AZ, Whitelaw DE, Lees
WR, Lovat LB, Ripley P, Jones L, Wyld P, Gillams A and Hatfield AW:
Photodynamic therapy for cancer of the pancreas. Gut. 50:549–557.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Verigos K, Stripp DCH, Mick R, Zhu TC,
Whittington R, Smith D, Dimofte A, Finlay J, Busch TM, Tochner ZA,
et al: Updated results of a phase I trial of motexafin
lutetium-mediated interstitial photodynamic therapy in patients
with locally recurrent prostate cancer. J Environ Pathol Toxicol
Oncol. 25:373–387. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Beck TJ, Kreth FW, Beyer W, Mehrkens JH,
Obermeier A, Stepp H, Stummer W and Baumgartner R: Interstitial
photodynamic therapy of nonresectable malignant glioma recurrences
using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg
Med. 39:386–393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Karakullukcu B, van Veen RL, Aans JB,
Hamming-Vrieze O, Navran A, Teertstra HJ, van den Boom F,
Niatsetski Y, Sterenborg HJ and Tan IB: MR and CT based treatment
planning for mTHPC mediated interstitial photodynamic therapy of
head and neck cancer: Description of the method. Lasers Surg Med.
45:517–523. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Wang AY and Yachimski PS: Endoscopic
management of pancreatobiliary neoplasms. Gastroenterology.
154:1947–1963. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Soares KC, Kamel I, Cosgrove DP, Herman JM
and Pawlik TM: Hilar cholangiocarcinoma: Diagnosis, treatment
options, and management. Hepatobiliary Surg Nutr. 3:18–34.
2014.PubMed/NCBI
|
|
93
|
Coelho-Prabhu N and Baron TH: Endoscopic
retrograde cholangiopancreatography in the diagnosis and management
of cholangiocarcinoma. Clin Liver Dis. 14:333–348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Lu Y, Liu L, Wu JC, Bie LK and Gong B:
Efficacy and safety of photodynamic therapy for unresectable
cholangiocarcinoma: A meta-analysis. Clin Res Hepatol
Gastroenterol. 39:718–724. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Talreja JP and Kahaleh M: Photodynamic
therapy for cholangiocarcinoma. Gut Liver. 4 (Suppl 1):S62–S66.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Jung CFM, Lavole J, Barret M, Ali EA,
Palmieri LJ, Dermine S, Barré A, Chaussade S and Coriat R: Local
therapy in advanced cholangiocarcinoma: A review of current
endoscopic, medical, and oncologic treatment options. Oncology.
97l:191–201. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Mohan BP, Chandan S, Khan SR, Kassab LL,
Ponnada S, Artifon ELA, Otoch JP, McDonough S and Adler DG:
Photodynamic therapy (PDT), radiofrequency ablation (RFA) With
biliary stents in palliative treatment of unresectable extrahepatic
cholangiocarcinoma: A systematic review and meta-analysis. J Clin
Gastroenterol. 56:e153–e160. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Buerlein RCD and Wang AY: Endoscopic
retrograde cholangiopancreatography-guided ablation for
cholangiocarcinoma. Gastrointest Endosc Clin N Am. 29:351–367.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Killeen RP, Torreggiani WC, Malone DE and
Brophy DP: Hemobilia as a potential complication in patients
treated with photodynamic therapy for unresectable
cholangiocarcinoma. Gastrointest Cancer Res. 3:802009.PubMed/NCBI
|
